首页 正文

Should academic therapeutic patents go to the highest bidder?

{{output}}
Universities conduct biomedical research with the self-stated goal of disseminating the benefits to the global public. Licensing therapeutic patents to the highest bidder is counterproductive to this aim, as it prioritizes income maximization over disseminatio... ...